Systemic flare and cutaneous ulceration following cytomegalovirus infection in a patient with anti-melanoma differentiation-associated protein 5 (MDA5) associated myositis: Diagnostic challenge during the time of coronavirus disease (COVID-19) pandemic-Reference-Cited by-同舟云学术

Systemic flare and cutaneous ulceration following cytomegalovirus infection in a patient with anti-melanoma differentiation-associated protein 5 (MDA5) associated myositis: Diagnostic challenge during the time of coronavirus disease (COVID-19) pandemic

Published:2021-10 Issue:4 Volume:43 Page:271-274
ISSN:1110-1164
Container-title:The Egyptian Rheumatologist
language:en
Short-container-title:The Egyptian Rheumatologist

Author:

Gupta Prakash,Kharbanda Rajat,Lawrence Able^ORCID,Gupta Latika

Publisher

Elsevier BV

Subject

Rheumatology

Reference19 articles.

1. Cutaneous ulceration in dermatomyositis: Association with anti–melanoma differentiation–associated gene 5 antibodies and interstitial lung disease;Narang;Arthritis Care Res,2015

2. Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis;Li;Oncotarget,2017

3. Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study;Tansley;Arthritis Res Ther,2014

4. Recent treatment of interstitial lung disease with idiopathic inflammatory myopathies;Kawasumi;Clin Med Insights Circ Respir Pulm Med,2015

5. Interstitial lung disease with anti-melanoma differentiation-associated protein 5 antibody: rapidly progressive perilobular opacity;Chino;Intern Med,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C);eBioMedicine;2024-06

2. Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease;Rheumatology International;2024-03-08

3. Other iatrogenic immunodeficiency‐associated lymphoproliferative disorders in anti‐melanoma differentiation‐associated protein 5 associated myositis—Truly iatrogenic or primary immunodeficiency?;International Journal of Rheumatic Diseases;2023-09

4. Autoinflammation and autoimmunity: More to what meets the eye;Indian Journal of Rheumatology;2023

5. COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis;Seminars in Arthritis and Rheumatism;2022-10